GIST trial
Credit: OHSU/Kristyna Wentz-Graff
Diana Dowd, center, talks with her friend, Lauri Roskamp, right, during an appointment at OHSU, Jan. 8, 2020. Dowd took part in a clinical trial treating a rare stomach cancer, GIST, which was recently approved by the FDA. The scans show a comparison of Dowd's stomach tumors after, left, and before her treatment. (OHSU/Kristyna Wentz-Graff) EDITOR'S NOTE: PERSONAL INFORMATION HAS BEEN REMOVED FROM THE XRAYS. NO OTHER CONTENT HAS BEEN MODIFIED.